The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia

S Nassereddine, CJ Lap, F Haroun, I Tabbara - Annals of hematology, 2017 - Springer
For decades, researchers have looked into the pathophysiology of acute myeloid leukemia
(AML). With the advances in molecular techniques, the two-hit hypothesis was replaced by a …

The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia

S Nassereddine, CJ Lap, F Haroun… - Annals of …, 2017 - search.proquest.com
For decades, researchers have looked into the pathophysiology of acute myeloid leukemia
(AML). With the advances in molecular techniques, the two-hit hypothesis was replaced by a …

The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia

S Nassereddine, CJ Lap, F Haroun… - Annals of …, 2017 - pubmed.ncbi.nlm.nih.gov
For decades, researchers have looked into the pathophysiology of acute myeloid leukemia
(AML). With the advances in molecular techniques, the two-hit hypothesis was replaced by a …

The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia.

S Nassereddine, CJ Lap, F Haroun… - Annals of Hematology, 2017 - europepmc.org
For decades, researchers have looked into the pathophysiology of acute myeloid leukemia
(AML). With the advances in molecular techniques, the two-hit hypothesis was replaced by a …

[引用][C] The Role of Mutant IDH1 and IDH2 Inhibitors in the Treatment of Acute Myeloid Leukemia.

S Nassereddine, CJ Lap, F Haroun… - Annals of …, 2017 - hsrc.himmelfarb.gwu.edu
"The Role of Mutant IDH1 and IDH2 Inhibitors in the Treatment of Acute " by Samah
Nassereddine, Coen J Lap et al. Home Search Browse Collections My Account About DC …